Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LORCASERIN HYDROCHLORIDE
- A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome
- Laboratory Screening of Lorcaserin for Alcohol Use Disorder
- Mechanisms of Lorcaserin for Smoking Cessation
- Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer
- Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
- Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients
- Lorcaserin for Cannabis Use Disorder
- A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy Participants
- Predictors of Lorcaserin-Induced Weight Loss
- Rebalancing the Serotonergic System in Cocaine Dependence
- Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
- Treatment With Lorcaserin for Cocaine Use: The TLC Study
- Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
- Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder
- Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
- Gene-by-Stress Interactions in Intervention Studies Significance
- Lorcaserin in the Treatment of Cocaine Use Disorder
- Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
- Combination Nicotine Patch / Lorcaserin for Smoking Cessation
- MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
- Lorcaserin Intra Venous Cocaine Effects
- Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
- Evaluating Muscle Weakness Improvement With Lorcaserin in ICU
- Addressing Post Cessation Weight Gain
- Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
- A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age
- Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
- Lorcaserin for Preventing Weight Gain Among Smokers
- Lifestyle Modification and Lorcaserin for Weight Loss Maintenance
- A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects
- Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
- A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
- Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age
- A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mul
- A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight
- Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study
- To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake
- Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment
- Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State
- Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users
- Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
- Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment
- BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management
- BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
- BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
Clinical trials list
click for details